ArticleScientific reports2018

Identification and pharmaceutical evaluation of novel frog skin-derived serine proteinase inhibitor peptide-PE-BBI (Pelophylax esculentus Bowman-Birk inhibitor) for the potential treatment of cancer.

Peng Lyu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.